316 related articles for article (PubMed ID: 24043310)
1. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.
Laurent G; de Boer VC; Finley LW; Sweeney M; Lu H; Schug TT; Cen Y; Jeong SM; Li X; Sauve AA; Haigis MC
Mol Cell Biol; 2013 Nov; 33(22):4552-61. PubMed ID: 24043310
[TBL] [Abstract][Full Text] [Related]
2. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells.
Nasrin N; Wu X; Fortier E; Feng Y; Bare' OC; Chen S; Ren X; Wu Z; Streeper RS; Bordone L
J Biol Chem; 2010 Oct; 285(42):31995-2002. PubMed ID: 20685656
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
Purushotham A; Schug TT; Xu Q; Surapureddi S; Guo X; Li X
Cell Metab; 2009 Apr; 9(4):327-38. PubMed ID: 19356714
[TBL] [Abstract][Full Text] [Related]
5. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase.
Laurent G; German NJ; Saha AK; de Boer VC; Davies M; Koves TR; Dephoure N; Fischer F; Boanca G; Vaitheesvaran B; Lovitch SB; Sharpe AH; Kurland IJ; Steegborn C; Gygi SP; Muoio DM; Ruderman NB; Haigis MC
Mol Cell; 2013 Jun; 50(5):686-98. PubMed ID: 23746352
[TBL] [Abstract][Full Text] [Related]
6. Sirt4 is a mitochondrial regulator of metabolism and lifespan in
Wood JG; Schwer B; Wickremesinghe PC; Hartnett DA; Burhenn L; Garcia M; Li M; Verdin E; Helfand SL
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1564-1569. PubMed ID: 29378963
[TBL] [Abstract][Full Text] [Related]
7. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
8. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
9. SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK.
Ho L; Titus AS; Banerjee KK; George S; Lin W; Deota S; Saha AK; Nakamura K; Gut P; Verdin E; Kolthur-Seetharam U
Aging (Albany NY); 2013 Nov; 5(11):835-49. PubMed ID: 24296486
[TBL] [Abstract][Full Text] [Related]
10. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
[TBL] [Abstract][Full Text] [Related]
11. Hepatic sirtuin 1 is dispensable for fibrate-induced peroxisome proliferator-activated receptor-α function in vivo.
Bonzo JA; Brocker C; Jiang C; Wang RH; Deng CX; Gonzalez FJ
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E824-37. PubMed ID: 24496310
[TBL] [Abstract][Full Text] [Related]
12. SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism.
Buler M; Aatsinki SM; Izzi V; Uusimaa J; Hakkola J
FASEB J; 2014 Jul; 28(7):3225-37. PubMed ID: 24687991
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.
Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ
Mol Cell Biol; 2016 Oct; 36(20):2553-67. PubMed ID: 27457618
[TBL] [Abstract][Full Text] [Related]
14. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
[TBL] [Abstract][Full Text] [Related]
15. Oxygen flux analysis to understand the biological function of sirtuins.
Wang D; Green MF; McDonnell E; Hirschey MD
Methods Mol Biol; 2013; 1077():241-58. PubMed ID: 24014411
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
17. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
18. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.
Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y
Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533
[TBL] [Abstract][Full Text] [Related]
19. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
